Ionizing radiation is a well-established human carcinogen. The risk of developing radiation-induced cancer has traditionally been estimated from cancer incidence among survivors of the atomic bombs dropped in Hiroshima and Nagasaki in 1945. These data provide the best estimate of human cancer risk over the dose range from 20 cGy to 2.5 Gy for low-linear energy transfer radiation such as X or gamma rays. The cancer risk at doses below 10 cGy, however, is uncertain and has been the subject of controversy for decades. A major point of contention is whether the risk is linear as the dose decreases or displays a more complicated relationship. Both the International Council on Radiation Protection (ICRP) (1) and the United States National Council on Radiation Protection (NCRP) (2) have recommended using a linear no-threshold (LNT) model in extrapolating cancer risk from higher doses where more...
Skip Nav Destination
Close
Article navigation
September 2006
Research Article|
September 01 2006
MEETING REPORT Low-Dose Radiation Risk Assessment Report of an International Workshop on Low Dose Radiation Effects held at Columbia University Medical Center, New York, New York April 3–4, 2006
Radiat Res (2006) 166 (3): 561–565.
Citation
MEETING REPORT Low-Dose Radiation Risk Assessment Report of an International Workshop on Low Dose Radiation Effects held at Columbia University Medical Center, New York, New York April 3–4, 2006. Radiat Res 1 September 2006; 166 (3): 561–565. doi: https://doi.org/10.1667/RR0713.1
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
0
Views
0
Citations
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner